WHO: 63 Countries Have Eliminated a Neglected Tropical Disease

Key Points

  • On 4 November 2026, WHO published a mid-term evaluation of its road map for neglected tropical diseases, covering 2021 to 2025.
  • WHO says 63 countries had eliminated at least one of these diseases by June 2026, up from 42 at the end of 2020, against a 2030 target of 100.
  • The number of people requiring interventions fell to 1.41 billion in 2024, 36% fewer than in 2010, against a 2030 target of a 90% reduction.
  • The report says most indicators remain below their 2030 targets and that financing has contracted in recent years.

Published .

A man in a black polo shirt and lanyard stands speaking with his hands raised under a white tent. A man in a red patterned shirt sits to his left, in front of a white van. Palm trees, a billboard and utility poles are behind them, and the tops of audience members' heads show along the bottom edge.
A Ministry of Health official gives opening remarks at a lymphatic filariasis mass drug administration event in Apia, Samoa, on 16 September 2023. Photo: Deirdre Marsac, U.S. Navy, public domain, via Wikimedia Commons, cropped and resized, photo source.

On 4 November 2026, the World Health Organization published its Global report on neglected tropical diseases 20262, a mid-term evaluation of the global plan to prevent, control, eliminate or eradicate a group of diseases that mostly affect people living in poverty. The headline from the executive summary is that by June 2026, 63 countries had eliminated at least one disease1 from the group, and the number of people requiring interventions fell to 1.41 billion in 2024, 36% fewer than in 20101. The same report says progress is uneven and that most targets are still out of reach.

What the report covers

The plan being assessed is the road map for neglected tropical diseases 2021 to 2030, which the Seventy-third World Health Assembly endorsed in 2020. According to the summary, it sets targets for 20 diseases and disease groups, since expanded to 21 with the addition of noma in December 20231. WHO says 2025 was the midpoint, so the evaluation looks at 2021 to 2025 and recommends priorities for 2026 to 2030. Its method combines a quantitative analysis of 71 global indicators with a structured qualitative assessment across 11 dimensions1, informed by more than 350 experts, programme managers, policy-makers and partners1, with oversight from an independent committee of external experts.

The headline numbers

The full report puts the 2010 starting point at 2.19 billion people requiring interventions2 against these diseases. By 2024 that figure was 1.41 billion, which is also a 19% reduction (324.5 million fewer people) from 20202, the year the previous road map ended. The 2030 target is a 90% reduction from the 2010 baseline, so the current 36% is well short of it. WHO also notes that most of these people (1.4 billion) still require mass treatment2 for diseases handled by preventive chemotherapy: lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases and trachoma.

On elimination, the report counts a country once WHO has certified, verified or validated the eradication, elimination or elimination as a public health problem of at least one of the diseases. It says 63 countries had done so as of June 20262, up from 42 at the end of 2020. The 2030 target is 100 countries. During 2021 to 2025, 31 countries eliminated at least one disease2, 16 of them acknowledged by WHO for the first time. Between 1 January and 30 June 2026, five more countries were acknowledged: Algeria, Australia, Libya and Tunisia for trachoma, and Chile for leprosy2.

One country, four diseases

The summary says Togo became the first country to eliminate four diseases1. The full report gives the breakdown for all 63 countries: 42 had eliminated one disease, 16 had eliminated two, four had eliminated three, and one (Togo) had eliminated four2. The count of completed WHO acknowledgement processes, which is tallied per country and disease rather than per country, reached 901. The report says the earliest was completed in 1997, when Pakistan was certified free of dracunculiasis (Guinea-worm disease) transmission2.

Other gains the report lists

Not every gain is a country count. The summary reports that 43 countries have adopted integrated strategies for skin-related neglected tropical diseases, already exceeding the 2030 target1. The full report says that target was passed 6 years ahead of schedule2. It also reports that more than 11.5 billion doses of medicines have been distributed to over 110 countries1, and that new medicines and vaccines reached regulatory milestones, notably fexinidazole, moxidectin, paediatric praziquantel and prequalified dengue and approved chikungunya vaccines1. Of the disease-specific indicators, three achieved their 2025 milestones: chikungunya vaccine development, reduced dengue case fatality rates and the availability of WHO-recommended polyspecific antivenoms for snakebite envenoming1.

Where the report says progress is short

The evaluation does not present these as a finished story. The summary says current estimates for most indicators remain below the 2030 targets1 and that both eradication programmes require accelerated progress to reach their 2030 targets1. Those two programmes are for Guinea-worm disease and yaws, and the full report says that as of 31 December 2025 progress stood at zero of two diseases eradicated2. Disability-adjusted life-years lost to these diseases fell by only 18% between 2015 and 2021, from 17.18 million to 14.14 million, but have stagnated since 20201. On dengue, the report notes that reported dengue deaths have more than doubled since 20162, while the case fatality rate has decreased, which WHO says may reflect earlier detection and better case management.

Money is the risk the summary names first. It says the most immediate risk is financial1, and that the contraction in NTD financing in recent years intensifies the other risks1. In the full report, WHO says funding for projects directly targeting these diseases increased by 6% in 2024 to US$ 274 million2, but remains substantially below pre-pandemic levels, and that the gains are overshadowed by the significant reductions in United States development assistance introduced in 20252. It adds that the United States, the United Kingdom and the Gates Foundation accounted for nearly four fifths of all funding between 2018 and 20242.

What WHO recommends for 2026 to 2030

The summary lists priorities that reinforce each other, starting with increasing and institutionalizing domestic financing while diversifying and maintaining external financing1. Others include treating conflict and displacement as structural realities for delivery, making integration with other health services the default model where it improves access and quality, embedding specialist skills in national institutions, funding a research agenda for products that need prequalification before 2030, and building equity into programme design. The report also says early work should begin on a successor framework1 for the period after 2030.

How to read the numbers

Two cautions apply. First, every figure above is WHO's own, from its own evaluation, and the counts of countries depend on WHO's formal acknowledgement processes. The full report says that for some diseases as of June 2026 countries have no clear global pathway to have their progress formally acknowledged2, even where elimination may already have been achieved. Second, the summary says remaining transmission is increasingly focal and heterogeneous, so aggregate figures can mask substantial variation1 between and within countries, so a national or global total does not describe every district.

Trivia

  1. How many countries had eliminated at least one neglected tropical disease by June 2026, according to WHO? 631.
  2. Which country became the first to eliminate four of these diseases? Togo1.
  3. What is the 2030 target for the number of countries that have eliminated at least one of these diseases? 1002.
  4. How many people required interventions against these diseases in 2024? 1.41 billion1.
  5. Which disease was added to the road map in December 2023, bringing it to 21 diseases and groups? Noma1.

Sources

  1. World Health Organization, Global report on neglected tropical diseases 2026: mid-term evaluation of the road map implementation. Executive summary, 4 November 2026. Accessed November 5, 2026.
  2. World Health Organization, Global report on neglected tropical diseases 2026: mid-term evaluation of the road map implementation, Geneva, 4 November 2026. Accessed November 5, 2026.